Enhanced tumor cell killing by ultrasound after microtubule depolymerization

Aditi Singh1,2, Ajay Tijore1, Felix Margadant1

  • 1Mechanobiology Institute National University of Singapore Singapore.

Insights

Low-frequency ultrasound induces cancer cell death (mechanoptosis) by disrupting microtubules and activating calcium channels. Combining ultrasound with microtubule-disrupting agents enhances this effect for potential tumor therapies.

Area of Science:

  • Biophysics
  • Cell Biology
  • Cancer Research

Background:

  • Tumor cells exhibit vulnerability to mechanical stress.
  • Mechanical stress can induce calcium-dependent apoptosis, termed mechanoptosis.
  • Low-frequency ultrasound alone can trigger mechanoptosis in tumor cells.

Purpose of the Study:

  • To investigate the cell-cycle phase sensitivity of tumor cells to mechanical stress.
  • To identify mechanisms underlying ultrasound-induced mechanoptosis.
  • To explore synergistic therapeutic strategies combining ultrasound and cell-cycle inhibitors.

Main Methods:

  • Utilized cell-cycle phase inhibitors to assess mechanoptosis sensitivity.
  • Investigated the role of microtubules and calcium channels (Piezo1) in ultrasound-induced mechanoptosis.
  • Examined the involvement of calpain protease, Myosin IIA, GEF-H1, and RhoA pathways.

Main Results:

  • Mitotic inhibitors that depolymerize microtubules significantly increased mechanoptosis.
  • Ultrasound treatment disrupted microtubules in tumor cells, but not normal cells.
  • Ultrasound-induced calcium entry via Piezo1 channels, calpain activation, and Myosin IIA contractility were crucial for mechanoptosis.
  • Microtubule disruption enhanced Myosin IIA contractility, promoting Piezo1 expression and activity.

Conclusions:

  • Tumor cells are sensitive to mechanical stress, particularly when microtubules are disrupted.
  • Ultrasound disrupts microtubules and triggers a calcium-dependent apoptotic pathway involving Piezo1 and Myosin IIA.
  • Synergistic application of ultrasound and microtubule-disrupting agents shows promise for enhancing cancer therapies.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K